ArticleJournal of virology2026
Identification of GRP78 as a novel host factor that facilitates zoonotic porcine deltacoronavirus internalization and replication via clathrin-mediated endocytosis.
Article in Journal of virology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Porcine deltacoronavirus (PDCoV) infects a wide range of hosts and can spread across species. Moreover, it is capable of infecting pAPN-knockout cell lines and pigs, suggesting that other important host factors facilitate PDCoV infection. To identify these important host factors, in this study, we employed co-immunoprecipitation (Co-IP) combined with liquid chromatography-tandem mass spectrometry (LC-MS/MS) to identify 19 significantly upregulated host membrane proteins that interact with the PDCoV S1 protein. Among these, glucose-regulated protein 78 (GRP78) was found to positively regulate PDCoV attachment and internalization, as validated by knockdown, blocking, and overexpression assays. Affinity assays confirmed a strong interaction between GRP78 protein and PDCoV S1 protein. This regulatory function of GRP78 operates in a pAPN-independent way. Mechanistically, we demonstrated that GRP78 interacts with the PDCoV S1 protein via its substrate-binding domain (SBD) and facilitates viral entry through clathrin-mediated endocytosis. Notably, the role of GRP78 in promoting viral entry and replication has also been applied by other coronaviruses, underscoring its potential as a conserved host factor in coronavirus infection. Together, these findings reveal a novel mechanism of PDCoV-host interaction that centers on GRP78-mediated viral attachment and internalization via clathrin-dependent endocytosis.IMPORTANCEPorcine deltacoronavirus (PDCoV) represents a significant zoonotic threat with pandemic potential, exhibiting a broad tissue tropism that underscores its capacity for cross-species spread. Current understanding of PDCoV entry mechanisms, however, remains largely limited to the porcine aminopeptidase N (pAPN), whose knockout fails to fully block infection-highlighting the critical need to identify alternative host entry factors. In this study, we identified the cell membrane protein GRP78 as a novel host factor that binds the C-terminal domain (CTD) of the PDCoV S1 protein via its substrate-binding domain (SBD), thereby mediating viral adsorption and internalization. Furthermore, GRP78 engages clathrin to facilitate viral internalization through endocytosis. Notably, GRP78-mediated entry operates independently of pAPN and demonstrates a degree of broad-spectrum activity relevant to other coronaviruses. Collectively, these findings provide new insights into the early entry mechanisms of PDCoV and identify GRP78 as a potential broad-spectrum target for antiviral intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.